EUVIMEDEUVIMED entdecken
Crossref

Oleanolic Acid Inhibits SCD1 Gene Expression to Ameliorate Fructose‐Induced Hepatosteatosis through SREBP1c‐Dependent and ‐Independent Mechanisms

Ling Yao iD, Meng Wang iD, Jun Zhang, Xianqin Luo, Chunlin Yuan, Ruojun Bai, Tongzhuang Wang, Yumeng Xi, Chunli Li, Dazhi Ke, Johji Yamahara, Yuhao Li und 3 weitere

Molecular Nutrition & Food Research · 2023

DOI: 10.1002/mnfr.202200533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2023. Verfasst von Ling Yao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, College of Traditional Chinese Medicine, 1 Yi…. Hauptthemen laut MEDLINE: Oleanolic Acid. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Chongqing Health Commission, Chongqing Education Committee, Chongqing Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scope The mechanisms of oleanolic acid (OA) regulating hepatic sterol regulatory element‐binding protein (SREBP) 1c/stearoyl‐CoA desaturase (SCD) 1 pathway to ameliorate fructose‐induced hepatosteatosis are investigated. Methods and results Rats treated with 10% w/v fructose solution are co‐administered by OA for 5 weeks, and then sacrifice after fasting for 14 h. OA reverses the fructose‐induced increase in hepatic triglyceride (TG) content and downregulates Scd1 mRNA expression. However, two upstream transcription factors, ChREBP and SREBP1c, remain at normal levels with or without fructose and/or OA. In vivo and in vitro studies using SREBP1c −/− mice and HepG2 cell models show that OA also inhibits SCD1 gene overexpression and high hepatic TG levels induced by fructose. On the other hand, in SCD1 −/− mice, when the fructose diet is supplemented with high levels of oleic acid (OLA) to compensate for the deficiency of SCD1, OA inhibits hepatic SREBP1c and lipogenic gene expression and reduces hepatic OLA (C18:1) production to improve fructose and/or OLA induced liver lipid deposition. Furthermore, OA promotes PPARα and AMPK to enhance fatty acid oxidation in fructose + OLA‐fed SCD1 −/− mice. Conclusion OA may inhibit SCD1 gene expression to ameliorate fructose‐induced hepatosteatosis through SREBP1c‐dependent and ‐independent mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oleanolic AcidRatsMiceAnimalsSterol Regulatory Element Binding Protein 1FructoseLiverTriglyceridesGene ExpressionStearoyl-CoA Desaturase

Stichwörter der Autor:innen

SCD1SREBP1chepatosteatosisoleanolic acidoleic acid

Substanzen

Sterol Regulatory Element Binding Protein 1Oleanolic AcidFructoseTriglyceridesStearoyl-CoA Desaturase

Autor:innen und Institutionen

  • Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, College of Traditional Chinese Medicine, 1 Yixueyuan Road, Chongqing Medical University, Yuzhong District, Chongqin…
  • Department of Pathology, Molecular Medicine and Cancer Research Center, Basic Medicine College, 1 Yixueyuan Road, Chongqing Medical University, Yuzhong District, Chongqing, 400016, P. R. China.
  • Institute of Life Sciences, Chongqing Medical University, 1 Yixueyuan Road, Yuzhong District, Chongqing, 400016, P. R. China.
  • The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongqing, 400010, P. R. China.
  • Pharmafood Institute, Kyoto, 602-8136, Japan.
  • Endocrinology and Metabolism Group, Sydney Institute of Health Sciences/Sydney Institute of Traditional Chinese Medicine, Sydney, NSW, 2000, Australia.

ORCID-Profile: Ling Yao, Meng Wang

Förderung

  • Chongqing Health Commission
  • Chongqing Education Committee
  • Chongqing Science and Technology Bureau
  • Chongqing Yuzhong Science and Technology Commission

Zitieren

APA

Yao, L., Wang, M., Zhang, J., Luo, X., Yuan, C., Bai, R., Wang, T., Xi, Y., Li, C., Ke, D., Yamahara, J., Li, Y., Yi, Y., Wang, S., & Wang, J. (2023). Oleanolic Acid Inhibits SCD1 Gene Expression to Ameliorate Fructose‐Induced Hepatosteatosis through SREBP1c‐Dependent and ‐Independent Mechanisms. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202200533

Vancouver

Yao L, Wang M, Zhang J, Luo X, Yuan C, Bai R, et al. Oleanolic Acid Inhibits SCD1 Gene Expression to Ameliorate Fructose‐Induced Hepatosteatosis through SREBP1c‐Dependent and ‐Independent Mechanisms. Molecular Nutrition & Food Research. 2023. doi:10.1002/mnfr.202200533

BibTeX
@article{Yao2023,
  author = {Yao, Ling and Wang, Meng and Zhang, Jun and Luo, Xianqin and Yuan, Chunlin and Bai, Ruojun and Wang, Tongzhuang and Xi, Yumeng and Li, Chunli and Ke, Dazhi and Yamahara, Johji and Li, Yuhao and Yi, Yongfen and Wang, Shang and Wang, Jianwei},
  title = {Oleanolic Acid Inhibits SCD1 Gene Expression to Ameliorate Fructose‐Induced Hepatosteatosis through SREBP1c‐Dependent and ‐Independent Mechanisms},
  journal = {Molecular Nutrition & Food Research},
  year = {2023},
  doi = {10.1002/mnfr.202200533}
}
Kostenlos starten →